Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 67,300
-800 (-1.17%)
Sep 22, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 439.81 billion as of September 22, 2026. Its market cap has decreased by -51.05% in one year.
Market Cap
439.81B
Enterprise Value
521.36B
Revenue
251.08B
Ranking
n/a
PE Ratio
30.43
Stock Price
67,300.00
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 439.81B, an increase of 513.18%. That is a compound annual growth rate of 10.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 439.81B | -48.14% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 703.16B |
| Hyundai Bioscience | 684.21B |
| Onconic Therapeutics | 683.39B |
| GI Innovation | 605.81B |
| Orum Therapeutics | 592.94B |
| GC Corp. | 437.14B |
| Proteina | 435.34B |
| AbClon | 388.27B |